Factors Associated with the Human Papillomavirus Vaccine Coverage in Gulu District, Uganda.

IF 1.7 Q2 PEDIATRICS

Adolescent Health Medicine and Therapeutics Pub Date : 2023-01-01 DOI:10.2147/AHMT.S397734

Isaac Odongo Ojok, John Baptist Ogwal, Brian Wwesige, Felix Bongomin, Franceska Akello

{"title":"Factors Associated with the Human Papillomavirus Vaccine Coverage in Gulu District, Uganda.","authors":"Isaac Odongo Ojok, John Baptist Ogwal, Brian Wwesige, Felix Bongomin, Franceska Akello","doi":"10.2147/AHMT.S397734","DOIUrl":null,"url":null,"abstract":"Background: Human papillomavirus (HPV) vaccination is an effective public health measure for the prevention of cancer of the cervix. We aimed to assess HPV vaccine coverage and associated factors in Gulu, Uganda.Methods: In October 2021, we conducted a cross-sectional study among girls aged 9 to 13 years residing in Pece-Laroo Division, Gulu City, Uganda. HPV vaccine coverage was defined as receipt of at least a dose of the HPV vaccine.Results: A total of 197 girls, with a mean age of 11±1.4 years, were enrolled. Most participants were of the Acholi tribe (89.3%, n=176), catholic (58.4%, n=115), and in primary 5 level of education (36%, n=71). Overall, 68(35%) participants had received the HPV vaccine. Factors associated with HPV vaccine utilization were, good knowledge of the HPV vaccine (adjusted odds ratio (aOR) =0.233, 95% confidence interval (95CI): 0.037-0.640, p=0.101), methods of HPV prevention (OR=0.320, 95CI: 0.112-0.914, p = 0.033), good knowledge of the importance of HPV vaccination (OR=0.458, 95% CI: 0.334-0.960, p=0.021), knowledge on frequency of HPV vaccination (OR=0.423, 95CI:0.173-0.733, p=0.059), and good mobilization (OR=0.443, 95% CI: 0.023-0.923, p=0.012).Conclusion: In this community-based study, only one third of eligible girls received the HPV vaccine. Public health interventions are recommended exponentially to enhance the utilization of the HPV vaccine in this community.","PeriodicalId":46639,"journal":{"name":"Adolescent Health Medicine and Therapeutics","volume":"14 ","pages":"87-96"},"PeriodicalIF":1.7000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/72/f9/ahmt-14-87.PMC10083017.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Adolescent Health Medicine and Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/AHMT.S397734","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PEDIATRICS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Human papillomavirus (HPV) vaccination is an effective public health measure for the prevention of cancer of the cervix. We aimed to assess HPV vaccine coverage and associated factors in Gulu, Uganda.

Methods: In October 2021, we conducted a cross-sectional study among girls aged 9 to 13 years residing in Pece-Laroo Division, Gulu City, Uganda. HPV vaccine coverage was defined as receipt of at least a dose of the HPV vaccine.

Results: A total of 197 girls, with a mean age of 11±1.4 years, were enrolled. Most participants were of the Acholi tribe (89.3%, n=176), catholic (58.4%, n=115), and in primary 5 level of education (36%, n=71). Overall, 68(35%) participants had received the HPV vaccine. Factors associated with HPV vaccine utilization were, good knowledge of the HPV vaccine (adjusted odds ratio (aOR) =0.233, 95% confidence interval (95CI): 0.037-0.640, p=0.101), methods of HPV prevention (OR=0.320, 95CI: 0.112-0.914, p = 0.033), good knowledge of the importance of HPV vaccination (OR=0.458, 95% CI: 0.334-0.960, p=0.021), knowledge on frequency of HPV vaccination (OR=0.423, 95CI:0.173-0.733, p=0.059), and good mobilization (OR=0.443, 95% CI: 0.023-0.923, p=0.012).

Conclusion: In this community-based study, only one third of eligible girls received the HPV vaccine. Public health interventions are recommended exponentially to enhance the utilization of the HPV vaccine in this community.

Abstract Image

查看原文本刊更多论文

乌干达古卢地区与人乳头瘤病毒疫苗覆盖率相关的因素。

背景:人乳头瘤病毒(HPV)疫苗接种是预防宫颈癌的有效公共卫生措施。我们的目的是评估乌干达Gulu的HPV疫苗覆盖率和相关因素。方法:2021年10月，我们对居住在乌干达古卢市佩西-拉鲁区9至13岁的女孩进行了一项横断面研究。HPV疫苗覆盖率定义为至少接种了一剂HPV疫苗。结果:共纳入197名女孩，平均年龄11±1.4岁。大多数参与者是Acholi部落(89.3%，n=176)，天主教徒(58.4%，n=115)和小学五年级教育(36%，n=71)。总体而言，68名(35%)参与者接种了HPV疫苗。与HPV疫苗使用相关的因素为:了解HPV疫苗(调整优势比(aOR) =0.233, 95%可信区间(95CI): 0.037 ~ 0.640, p=0.101)、HPV预防方法(OR=0.320, 95CI: 0.112 ~ 0.914, p= 0.033)、了解HPV疫苗接种的重要性(OR=0.458, 95% CI: 0.334 ~ 0.960, p=0.021)、了解HPV疫苗接种的频率(OR=0.423, 95CI:0.173 ~ 0.733, p=0.059)和良好的动员(OR=0.443, 95% CI: 0.023 ~ 0.923, p=0.012)。结论:在这项基于社区的研究中，只有三分之一的符合条件的女孩接种了HPV疫苗。建议采取公共卫生干预措施，以提高该社区HPV疫苗的使用率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Adolescent Health Medicine and Therapeutics PEDIATRICS-

自引率

0.00%

发文量

审稿时长

16 weeks

期刊介绍： Adolescent Health, Medicine and Therapeutics is an international, peer reviewed, open access journal focusing on health, pathology, and treatment issues specific to the adolescent age group, including health issues affecting young people with cancer. Original research, reports, editorials, reviews, commentaries and adolescent-focused clinical trial design are welcomed. All aspects of health maintenance, preventative measures, disease treatment interventions, studies investigating the poor outcomes for some treatments in this group of patients, and the challenges when transitioning from adolescent to adult care are addressed within the journal. Practitioners from all disciplines are invited to submit their work as well as health care researchers and patient support groups. Areas covered include: Physical and mental development in the adolescent period, Behavioral issues, Pathologies and treatment interventions specific to this age group, Prevalence and incidence studies, Diet and nutrition, Specific drug handling, efficacy, and safety issues, Drug development programs, Outcome studies, patient satisfaction, compliance, and adherence, Patient and health education programs and studies.